371 related articles for article (PubMed ID: 22113154)
21. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
Béchard L; Morasse-Bégis M; Corbeil O; Hakim JR; Malenfant E; Brodeur S; Huot-Lavoie M; Essiambre AM; Demers MF; Roy MA
J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):391-395. PubMed ID: 35546087
[TBL] [Abstract][Full Text] [Related]
22. Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.
Noël MC; Powell V; Burton L; Panda R; Remington G
J Clin Psychopharmacol; 2019; 39(4):380-385. PubMed ID: 31205188
[TBL] [Abstract][Full Text] [Related]
23. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
Huang TL
Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
[TBL] [Abstract][Full Text] [Related]
24. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
Dunk LR; Annan LJ; Andrews CD
Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
[TBL] [Abstract][Full Text] [Related]
25. Clozapine Rechallenge After Neutropenia or Leucopenia.
Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptic malignant syndrome associated with clozapine treatment.
Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
[TBL] [Abstract][Full Text] [Related]
27. A case of clozapine-induced neuroleptic malignant syndrome.
Miller DD; Sharafuddin MJ; Kathol RG
J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
[TBL] [Abstract][Full Text] [Related]
28. Successful clozapine rechallenge after myopericarditis: a case report.
Boscutti A; Cereda G; Lazzaretti M; Enrico P; Fiorentini A; Prunas C; Callari A; Fontana E; Delvecchio G; Brambilla P
Int Clin Psychopharmacol; 2022 Jul; 37(4):179-181. PubMed ID: 35661661
[TBL] [Abstract][Full Text] [Related]
29. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
30. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
31. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
Weller M; Kornhuber J
Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
[TBL] [Abstract][Full Text] [Related]
32. A review of clozapine safety.
Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
[TBL] [Abstract][Full Text] [Related]
33. [Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review].
Berger SJ; Hofer A
Neuropsychiatr; 2023 Sep; 37(3):130-135. PubMed ID: 37389803
[TBL] [Abstract][Full Text] [Related]
34. Neuroleptic malignant syndrome and clozapine.
Reddig S; Minnema AM; Tandon R
Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
[TBL] [Abstract][Full Text] [Related]
35. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
36. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
[TBL] [Abstract][Full Text] [Related]
37. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
38. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
[TBL] [Abstract][Full Text] [Related]
39. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
Sachdev P; Kruk J; Kneebone M; Kissane D
J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
[TBL] [Abstract][Full Text] [Related]
40. Clozapine-induced neutropenia in children: management with lithium carbonate.
Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
